SkyCell

PharmaLifeScience News

...

US pharma firms assess potential of shifting work from Ireland if tariffs hit hard
A number of US pharma companies are “scenario planning” around moving some manufacturing out of Ireland if Donald Trump goes ahead with swingeing tariffs on the EU, as he has threatened.
READ MORE
...

Google promises new AI models for drug discovery
Google promises new AI models for drug discoveryPhil.TaylorWed, 19/03/2025 - 12:46Bookmark thisPhil.TaylorWed, 19/03/2025 - 12:46Bookmark this
READ MORE
...

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia
Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.
READ MORE

5 takeaways on the Critical Medicines Act

How Japan is pioneering the future of oncology clinical trials through DCT

Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers

AstraZeneca to expand cell therapy capabilities with $1bn EsoBiotec acquisition

Ireland could lose pharma tax to US after Trump accusations, experts warn

Phytogene Offers a Greener, Cheaper Alternative for Producing Pharmaceuticals

Gantenerumab 'shows sign of preventing Alzheimer's dementia'

UVA scientists develop AI tool to accelerate the development of new disease treatments

Initial leap of faith inspires today’s fast-growing digital clinical trial movement

Curevo procures $110m and former-GSK exec for shingles vaccine candidate

Roche taps Oxford BioTherapeutics for cancer drug discovery

UK is becoming an 'outlier' for pharma, hitting investment

Sapio Sciences makes AI-Native drug discovery seamless with NVIDIA BioNeMo

Big tech meets biotech: Recursion and the AI gold rush in pharma

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

Xbrane in agreement to sell biosimilar candidate and parts of its organization to Alvotech

Albanese says PBS ‘not up for negotiation’ after US pharma complains to Trump about scheme

Investigating key strategies for optimising clinical trial supply chains in 2025

AstraZeneca enters licensing agreement with Alteogen

Insilico raises $110m to develop drug pipeline and AI platform

Simon Harris to update Cabinet on impacts of US tariffs and EU retaliation
Ellab